KCT0000801招募中未知
A Comparison of LY2605541 versus Human Insulin NPH as Basal Insulin Treatment in Insulin-Naive Patients with Type 2 Diabetes Mellitus not Adequately Controlled with 2 or more Oral Antihyperglycemic Medications: An Open-Label,Randomized Study The IMAGINE 6 Study
Eli Lilly Korea0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •Patients with T2DM who are 18 years or older,
- •treated with at least 2 OAMs for at least 3 months prior to the study and who are insulin naive and have a baseline
- •HbA1c of 7.0% to 11.0% as determined by the central laboratory at Visit 1 are eligible for this study.
排除标准
- •should not have used insulin therapy in the past 2 years and should not have been treated with glucagon-like
- •peptide-1 (GLP-1) receptor agonist, rosiglitazone, pramlintide, or weight-loss medication within 3 months of Visit
- •1. Patients using DPP-IV inhibitors that are approved for use in combination with insulin are allowed to participate
- •in the study. Patients using pioglitazone may be allowed to participate depending on restrictions for use in
- •combination with insulin or metformin described in the local label. Patients should not have had any episodes of
- •severe hypoglycemia, diabetic ketoacidosis, or hyperosmolar state/coma within 6 months prior to Visit 1.
研究者
相似试验
进行中（未招募）
不适用
A 6-month study to compare a new long-acting insulin and Human Insulin NPH in Patients with type 2 diabetesMedDRA version: 14.1Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 100000004861Type 2 Diabetes MellitusEUCTR2012-003941-13-DEEli Lilly and Company630
进行中（未招募）
1 期
A 6-month study to compare a new long-acting insulin and Human Insulin NPH in Patients with type 2 diabetesMedDRA version: 16.0Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 100000004861Type 2 Diabetes MellitusEUCTR2012-003941-13-CZEli Lilly and Company630
进行中（未招募）
不适用
A 6-month study to compare a new long-acting insulin and Human Insulin NPH in Patients with type 2 diabetesMedDRA version: 16.0Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 100000004861Type 2 Diabetes MellitusEUCTR2012-003941-13-PLEli Lilly and Company630
进行中（未招募）
不适用
A 6-month study to compare a new long-acting insulin and Human Insulin NPH in Patients with type 2 diabetesMedDRA version: 15.1Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 100000004861Type 2 Diabetes MellitusEUCTR2012-003941-13-ESilly S.A.630
进行中（未招募）
不适用
A 6-month study to compare a new long-acting insulin and Human Insulin NPH in Patients with type 2 diabetesType 2 Diabetes MellitusMedDRA version: 14.1Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2012-003941-13-HUEli Lilly and Company630